Myonex ApS: Financial statements 2021
CVR: 39905094
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Myonex ApS (CVR 39905094) has filed annual accounts for 2021. In 2021, the company reported a gross profit of EUR 8,057,814,000 and a net result of EUR 6,237,759,000 compared with EUR -104,968 the year before. Equity in the 2021 report amounted to EUR 6,115,100,000. The solvency ratio was 33.8%.
- Gross Profit
- EUR 8,057,814,000
- Profit/Loss
- EUR 6,237,759,000
- Equity
- EUR 6,115,100,000
- Total Assets
- EUR 18,101,548,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 8.1B EUR | 6.2B EUR | 6.1B EUR | - |
| 2020 | - | -104K EUR | -105K EUR | -179K EUR | - |
Official annual report
Find more companies like Myonex ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Myonex ApS has published its annual report for 2020. Gross profit came to DKK -104,398, and the net result was DKK -104,968.
About Myonex ApS
Myonex ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Myoderm ApS. The management consists of Gregory Thomas Lavin and Michael Allen Cohen. The company is owned by Myonex, LLC. In 2025, the company reported a gross profit of EUR 1,009,020 and a net result of EUR 580,466 compared with EUR 2,155,499 the year before. Equity in the 2025 report amounted to EUR 19,516,469.